ADC Review

Format Your Manuscript for Submission

ADC Review | Journal of Antibody-drug Conjugates is an open access, peer reviewed journals publishing original research, reviews and OpEds/Editorials

Word count
In most cases, we do not impose strict limits on word count or page number. We do recommend that articles are between 1,000 - 6,500 words long (for OpEd/Editorials we recommend a minimum of 750 words). However, more important than word length is that manuscripts submitted for publications are written in an accessible, engaging, provocative style and following these basic guidelines:

• Manuscripts should ideally be no more than 15 typeset pages
• The main text should be no more than 6,000 words (not including Abstract, Methods, References and figure legends);
• The title should be no more than 25 words
• The abstract should be no more than 350 words;
• Manuscripts should be submitted

Abstract
References should not be included in the suggested abstract. The Abstract should serve as both a general introduction to the topic and as a brief, non-technical, summary of the main results and their (possible) implications.

Manuscript
The manuscript text file should start with a title page. The title page should shows the name and affiliations of the authors(s) and their contact information. In case of multiple authors, the title page should also identifying the corresponding author. For the main body of the manuscript text we recommend organizing it in a way that best suits your research. We also recommend the following structure which is suitable in most cases:

• Introduction
• Results (+ subheadings)
• Discussion (no subheadings)
• Methods

The main body of text should be followed by:

• References (limited to approximately 50 references)
• Acknowledgements (optional)
• Author contributions (names must be given as initials)
• Additional Information (including a Conflict of Interests Statement)
• Figure legends (these are limited to 450 words per figure)
• Tables (maximum size of one per page)
• Footnotes should not be used.

If necessary, a limited number of molecular structure graphics and mathematical equations as well as a limited to 8 (figures and/or tables) can be added to clarify or enhance the content of the manuscript. However, to enable typesetting of papers, we advise making the number of display items commensurate with your overall word length.

The submitted manuscript should also include:

• A cover letter (see below);
• Individual figure files;
• Optional supplementary information files.

All supplementary information should be combined and supplied as a single separate file, preferably in PDF format.

Cover letter
When submitting your manuscript, note that the cover letter should include:

• The affiliation and contact information of the corresponding author;
• An explanation of why the work is appropriate for inclusion in ADC Review | Journal of Antibody-drug Conjugates ;
• The names and contact information of possible independent reviewers you consider suitable to review the manuscript;
• The names of any referees you would like to exclude from reviewing the manuscript

Writing your manuscript
ADC Review | Journal of Antibody-drug Conjugates read by a diverse readership of scientists, many of whom are non-native English speakers as well as physicians, healthcare providers, regulators and others. While our readers have a shared basic knowledge of science, not everyone will be familiar with the specific language related to antibody-drug conjugates or their clinical application. Our editorial team recommends writing your manuscript and scientific findings in concise and clear language:

• If possible, avoid technical jargon, explaining the meaning when this is unavoidable;
• When using abbreviations, use the full description or legend when it appears the first time, before using the abbreviation. This is especially important when the abbreviation is not standard;
• Explain the background, rationale and main conclusions of the study;
• Develop the abstracts, titles and sub-titles in a readily understood language;
• Ask a colleague with different scientific expertise to review the manuscript before submitting

Editing services
As part of the submission and management of manuscripts, Sunvalley Communication, the publisher of ADC Review | Journal of Antibody-drug Conjugates, does not provide in-depth editing as part of the submission and production process. If your manuscript would benefit from an external editorial service, consider contacting our editorial and editing service before the first submission or at the revision stage. Using the service of our editorial and editing service is not free, is at your own expense and doesn’t ensure that the manuscript is accepted for publication.

Methods
Our editorial team recommends limiting the Methods section to 1,500 words. To be considered for publication, include adequate experimental and characterization data allowing reproduction of the science. To succeed, include:

• Descriptions of standard protocols and experimental procedures;
• Identify commercial suppliers of reagents or instrumentation when the source is critical to the outcome of the experiments.
• Identify sources for any kits you use in your procedures;
• Include any experimental protocols that describe the synthesis of novel compounds;
• In case of a novel compound, use a systematic description and put its bold Arabic numeral in the heading for the experimental protocol, indicating it thereafter by its assigned, bold numeral.
• At all times, clearly describe the experimental protocol in detail, referring to amounts of reagents in parentheses, when possible (e.g. 1.03 g, 0.100 mmol);
• Use standard abbreviations for reagents and solvents.
• At all times, clearly identify the safety hazards posed by reagents or protocols;
• Make sure to report isolated mass and percent yields at the end of each protocol;

Statement of ethical approval
When reporting experiments on live vertebrates (or higher invertebrates), humans or human samples, it is required to include a statement of ethical approval in the Methods section.

References
References should be included in NLM format. It is essential to format the references correctly, because, when possible, they will be linked electronically to external databases. Include clinical trials, published conference abstracts, and patents in a separate overview, not part of the references. For mor informatiuon about references, please go to More about references

Conflict of interests
Public trust in the scientific process and the credibility of published peer reviewed articles depend in part on how transparently conflicts of interest are handled during the planning, implementation, writing, peer review, editing, and publication of scientific work. Hence, when submitting your manuscript, you must include a conflict of interests statement.

If there is no conflict of interest, you should include a statement declaring this. This statement must be explicit and unambiguous, describing any potential conflict of interest (or lack thereof) for EACH contributing author.

To help guide the process, complete and return the Conflict of Interest form developed by the International Committee of Medical Journal Editors. .

Keep in mind that the information you provide will be used as the source of truth when your manuscript is accepted for publication is published.

Ethics declarations
If your research includes human or animal subjects, you will need to include the appropriate ethics declarations.

Approval for animal experiments
For experiments involving live vertebrates and/or higher invertebrates, make sure that the statement:

• Identifies the ethical approval committee/Institutional Review Board that approved the experiments, including any relevant details.
• Confirms that all experiments were performed in accordance with relevant named guidelines and regulations.

Approval for human experiments
For experiments involving human subjects (or tissue samples), the statement must:

• Identify the ethical approval committee/Institutional Review Board that approved the experiments, including any relevant details.
• Confirms that all experiments were performed in accordance with relevant named guidelines and regulations.
• Confirms that informed consent was obtained from all participants and/or their legal guardians.
• Consent to participate/Consent to publish
• Mention if a waiver was obtained for the study and reason for the waiver.
• Alle authors should confirm that the study and all experiments were conducted in accordance with the Helsinki Declaration as revised in 2013.

At all times:

• Study participant names, as well as all other personally identifiable information, must be removed from all text/figures/tables/images.
• In case of using pictures, use black bars/shapes or blurring to obscure the eyes/facial region of study participants as a means of anonymization.
• For manuscripts that include information or images that could lead to identification of a study participant, include a statement that confirms that informed consent was obtained to publish the information/image(s) in an online open access peer reviewed publication.

Supplementary Information
Submit any Supplementary Information together with the manuscript. This allowed our editorial team to our independent advisory board reviewers during peer-review. Before submission, carefully check your the Supplementary Information since any modification after the manuscript has been accepted for publication requires a formal correction.

Additional questions
If you have any additional questions about the preparation of your manuscript, manuscript submission and the peer review process, please email our editorial team.